 we report on our financial results for the fourth quarter and full year of 2021 and discuss recent corporate updates including a $175 million debt refinancing with Hayfin. 
 we also report on the growth of our plasma collection center network and the successful conclusion of the supply chain robustness initiatives undertaken at the company manufacturing facility in the fourth quarter of 2021. 
 we also discuss our outlook for the remainder of 2022 and beyond.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 